Detalhe da pesquisa
1.
CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope cross-react with selective seasonal coronaviruses.
Immunity
; 54(5): 1055-1065.e5, 2021 05 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33945786
2.
Impact of HLA-DR Antigen Binding Cleft Rigidity on T Cell Recognition.
Int J Mol Sci
; 21(19)2020 Sep 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-32992915
3.
Elevated BMI reduces the humoral response to SARS-CoV-2 infection.
Clin Transl Immunology
; 12(12): e1476, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38050635
4.
Lineage-restricted neoplasia driven by Myc defaults to small cell lung cancer when combined with loss of p53 and Rb in the airway epithelium.
Oncogene
; 41(1): 138-145, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34675406
5.
Homologous peptides derived from influenza A, B and C viruses induce variable CD8+ T cell responses with cross-reactive potential.
Clin Transl Immunology
; 11(10): e1422, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36275878
6.
Protein purification and crystallization of HLA-A∗02:01 in complex with SARS-CoV-2 peptides.
STAR Protoc
; 2(3): 100635, 2021 09 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34124695
7.
Molecular Basis of a Dominant SARS-CoV-2 Spike-Derived Epitope Presented by HLA-A*02:01 Recognised by a Public TCR.
Cells
; 10(10)2021 10 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34685626
8.
The presentation of SARS-CoV-2 peptides by the common HLA-A∗02:01 molecule.
iScience
; 24(2): 102096, 2021 Feb 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-33521593
9.
CD4+ T cell-mediated HLA class II cross-restriction in HIV controllers.
Sci Immunol
; 3(24)2018 06 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29884618